Loading...
Loading...
In a report released Tuesday, Morgan Stanley analyst Simeon Gutman initiated coverage on
GNCGNC with an Equal-weight rating and $39.00 price target.
Gutman expects the health supplement retailer to have domestic square footage growth of four to five percent, positive risk/reward skewness, but bottom line growth potentially below average for the next few quarters. Morgan Stanley analysts like GNC's global expansion, multi-channel expansion with its manufacturing and franchise division, opportunity in its e-Commerce site.
Gutman claims GNC is currently inexpensive, trading at 10x his 2015 EPS estimate and claims EPS has the potential to grow in the low- to mid-teens as soon as they improve comps.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in